Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5711817 | 6863598 | I | 5711817-5 | 20080201 | 20080327 | 20080416 | EXP | 2008JP001625 | ASTELLAS PHARMA US, INC. | 25 | YR | M | N | 20080403 | MD | JAPAN |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5711817 | 1009812570 | PS | PROTOPIC | 1 | TOPICAL | TOPICAL | D | D | 50777 | ||
5711817 | 1009862073 | SS | GENINAX(GARENOXACIN MESILATE HYDRATE) | 2 | ORAL | 400 MG, /D, ORAL | U | D | |||
5711817 | 1009862076 | SS | AZITHROMYCIN | 1 | ORAL | ORAL | U | D | |||
5711817 | 1009862078 | SS | AVELOX | 1 | ORAL | ORAL | U | D |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5711817 | 1009812570 | DERMATITIS ATOPIC |
5711817 | 1009862073 | PYREXIA |
5711817 | 1009862076 | PYREXIA |
5711817 | 1009862078 | PYREXIA |
Outcome of event
Event ID | OUTC COD |
---|---|
5711817 | HO |
Reactions reported
Event ID | PT |
---|---|
5711817 | ENDOCARDITIS |
5711817 | PLATELET COUNT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | RPSR COD |
---|---|
5711817 | FGN |
5711817 | HP |
5711817 | OTH |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5711817 | 1009862073 | 20080201 | 20080201 | ||
5711817 | 1009862076 | 20080101 | |||
5711817 | 1009862078 | 20080101 |